Coffee Consumption & NASH in the French Population.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05480696` - Soluble Fibre Supplementation in NAFLD	Phase 1
Completed	`NCT04573543` - The Role of Immune Semaphorins in NAFLD
Completed	`NCT01695083` - Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
Not yet recruiting	`NCT05605158` - Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis	Phase 3
Completed	`NCT01761370` - Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)	N/A
Withdrawn	`NCT03864835` - NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal	N/A
Completed	`NCT05357352` - Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis
Not yet recruiting	`NCT03803540` - Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis	Phase 1
Completed	`NCT02395900` - The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease	Phase 2/Phase 3
Completed	`NCT01791959` - The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis	Phase 2/Phase 3
Recruiting	`NCT05821010` - Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis	Phase 2
Recruiting	`NCT03734510` - The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled Study	N/A
Recruiting	`NCT02721264` - Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.	N/A
Terminated	`NCT03883607` - Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)	Phase 2
Completed	`NCT03863574` - Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis	Phase 2
Recruiting	`NCT03377153` - The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease	N/A
Recruiting	`NCT03377140` - The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease	N/A
Active, not recruiting	`NCT04669158` - Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis	Phase 1/Phase 2
Recruiting	`NCT06176079` - Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Withdrawn	`NCT01384578` - Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis	Phase 3

NCT number	NCT03432377
Study type	Observational
Source	Versailles Hospital
Contact
Status	Completed
Phase
Start date	November 15, 2017
Completion date	November 17, 2020

Coffee Consumption and NASH in the French Population. — COCANASH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms